Jump to content
RemedySpot.com

Flu virus still packs plenty of surprises

Rate this topic


Recommended Posts

Posted

Flu virus still packs plenty of surprises

DAVID STEINKRAUS journalTimes.com , December 22, 2010

It has been more than a year since the panic over H1N1 influenza, since the

vaccine shortages, the declaration of a global pandemic and fears that there

would be a repeat of 1918 when influenza killed between 50 and 100 million

people worldwide.

With a global pandemic in the past and another flu season upon us, what do we

face this year? What have we learned? Are better vaccines and more responsive

vaccine production in the offing? The answers are not much, so far not much, and

maybe.

Those answers are indefinite because of the nature of the influenza virus

itself. It is an ancient foe with a history stretching back into time along with

that of humanity, and it is a changeable foe. Like humans themselves, the virus

has a key survival advantage in its ability to change and adapt.

The virus

First isolated in 1933, the influenza virus consists of eight strands of RNA

which is a complement to DNA and serves as a template for proteins. The flu

virus makes eight proteins. What makes it such a difficult target is that it

changes constantly which is why this year's flu vaccine is different from last

year's. The other factor is that when two flu viruses meet in the same animal,

the bits of genetic material can combine in new ways.

The H1N1 virus which appeared last year and caused such concern was a

combination of two genes from a swine flu, two genes from a bird flu, one human

gene, and then genes from European swine for the protein involved in assembling

the finished virus and for making the enzyme that cuts the assembled virus free

of its host cell.

" All those genes have been seen before but not in that particular combination, "

said Lamb, professor of molecular and cellular biology in the

Department of Molecular Biosciences at Northwestern University in ton, Ill.

That recombination, properly called a reassortment, occurred in some animal. No

one is certain how a European swine was involved nor where the reassortment

happened.

" So that fact is all of a sudden this virus initiated an epidemic in Mexico, and

then that spread worldwide. That's it. That's all we know, " said Yoshihiro

Kawaoka. He is a professor of virology in the University of Wisconsin School of

Veterinary Medicine and a leading experts on influenza.

One key difference in last year's H1N1 flu is that younger people were much more

susceptible than usual. Typically it is the very old and the very young who are

most at risk from flu.

" I don't think it was any more virulent. In fact, most of the people got really

mild illnesses, " said Dr. Fauci, director of the National Institute of

Allergy and Infectious Diseases.

Missing knowledge

What we know about the flu virus is all on the outside. Scientists characterize

the virus by two molecules, as in H1N1. The H is hemagglutinin which allows the

virus to identify and attach to cells. The N is neuraminidase, an enzyme that

cuts the connection with the host cell and sets the new virus free to float off

and infect a new cell.

We don't understand what makes the virus more or less transmissible in humans.

If the virus can attach to cells in the upper airway, it can be transmitted

easily. What happens then depends on the body's ability to fight the disease.

" We know what some of the virulence factors are, but I think it's fair to say we

don't know what they all are, " Lamb said.

What we're really missing is what is happening inside the cell, all the

interactions between the viral proteins and the cell it infects.

Vaccine

We have a vaccine system that is not very speedy. In the spring researchers take

samples of the viruses in circulation, and then pharmaceutical manufacturers

spend several months growing the viruses in chicken eggs, purifying them,

inactivating them and packaging the doses for use in humans. But this is an

obviously slow process, and it cannot be quickly adapted to meet the threat of a

new virus such as H1N1.

One impediment to reforming the vaccine system is economic. Only two primary

companies make vaccine, and they have a heavy investment in the current

technology, Kawaoka said. In theory one could make a vaccine more quickly in a

cell culture than in an egg, he said, but such techniques would still have to be

proven through clinical trials in humans. And, Lamb said, there is the problem

of scaling up for production; what works on a lab bench in small batches becomes

a massive engineering problem when manufacturers try to meet the production

demands for the nation's population.

" You should never have to grow the virus at all, " Fauci said.

Ideally we would use the techniques of genetic analysis to break down the genome

of a new virus, then add bits of DNA to the genome of a cell so that it produces

the viral proteins for a vaccine.

In August, researches from the NIAID reported progress on creating a universal

vaccine, in other words one that could work against more than one type of flu.

The research team created antibodies from parts of the flu genome that change

little from year to year. Boosted by a dose of seasonal flu virus, this

universal vaccine was effective against H1N1 strains dating back to 1934, the

team reported in Science magazine.

Eternal evolution

Given the fact that the flu virus has only a few strands of genetic material,

and that not every part of its genome changes, one might think that after a

while the virus will run out of possible combinations and we can catch up.

" Won't happen. It's evolution, " Kawaoka said. " We may not call it influenza

virus any more in 1,000 or 1 million years from now. "

But the virus will still be with us as it has been with us for what we know of

human history. Pathogens do become less virulent over time, he said; they must

or they risk wiping themselves out as they destroy their hosts.

Influenza and we are old friends, perhaps a bit too cozy because familiarity in

this case is breeding not contempt but a certain amount of indifference that

leaves us vulnerable to the sudden appearance of a new, and deadly, flu.

http://www.journaltimes.com/lifestyles/health-med-fit/article_6519be90-0d3e-11e0\

-9450-001cc4c03286.html

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...